SLENYTO NEWS

WORLD SLEEP CONGRESS 2022 TAKES PLACE ON MARCH 14TH IN ROME, ITALY

Slenyto is back to the international scene with a significant presence in the WSC 2022 in Rome.
Satellite Symposium “Advances in insomnia in ASD – from research to clinical practice” is scheduled for Monday, March 14th at 12:30.

Top notch international experts (Prof Bruni, Prof Mallow and Prof Gringras) will discuss the new advances in genetics and biochemistry of insomnia in ASD, and present the long term efficacy and safety of Slenyto.

In addition, we will have scientific presence by2 interesting posters which will be presented:
• “Children with autism and insomnia utilize twice the amount of health services than their counterparts” presented by Prof.Ilan Dinstein from Israel (Poster #217, 5:30-6:15PM)
• “Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder” presented by Dr. Eva Arais Vivas from Spain (Poster #194, 6:15-7:00PM)

On the next day (Tuesday), Carmen Schroder will be presenting the poster on the use of slenyto in children with ASD (case studies):

• “Modalities of pediatric appropriate PR melatonin (PedPRM) prescription in children with ASD and insomnia – a case studies” (Poster #172, 6:15-7:00PM)

Slenyto booth constructed by Fidia Pharmaceutici ( Italy) will host also the international team which will commercially support the scientific events.

Looking forward to seeing you and your clients there!
A presto a Roma!

SLENYTO PRICE CHANGE IN PORTUGAL

Slenyto Price in Portugal was updated due to a change in local regulations and as of Feb. 1st 2022 will be as follow:

  • Text size: A A A
  • Circadin
  • Recent news

    • Slenyto is now available in Spain!
    • Neurim Pharmaceuticals is attending World Sleep Congress 2022, March 11-16, Rome, Italy
    • Neurim conducted a survey via Brandman Research, assessing the characteristics of insomnia in children with ASD and the distress it causes to the children and their families
  • Partners

    Partners